IL133493A0 - Intermediates for the preparation of synthetic excitatory amino acids - Google Patents

Intermediates for the preparation of synthetic excitatory amino acids

Info

Publication number
IL133493A0
IL133493A0 IL13349399A IL13349399A IL133493A0 IL 133493 A0 IL133493 A0 IL 133493A0 IL 13349399 A IL13349399 A IL 13349399A IL 13349399 A IL13349399 A IL 13349399A IL 133493 A0 IL133493 A0 IL 133493A0
Authority
IL
Israel
Prior art keywords
intermediates
preparation
amino acids
excitatory amino
synthetic excitatory
Prior art date
Application number
IL13349399A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/496,643 external-priority patent/US5750566A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL133493A0 publication Critical patent/IL133493A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/38Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/18All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13349399A 1994-08-12 1999-12-13 Intermediates for the preparation of synthetic excitatory amino acids IL133493A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28995794A 1994-08-12 1994-08-12
US33734994A 1994-11-10 1994-11-10
US08/496,643 US5750566A (en) 1994-08-12 1995-06-29 Synthetic excitatory amino acids

Publications (1)

Publication Number Publication Date
IL133493A0 true IL133493A0 (en) 2001-04-30

Family

ID=27403949

Family Applications (2)

Application Number Title Priority Date Filing Date
IL11491095A IL114910A (en) 1994-08-12 1995-08-11 Synthetic excitatory amino acids their preparation and pharmaceutical compositions containing them
IL13349399A IL133493A0 (en) 1994-08-12 1999-12-13 Intermediates for the preparation of synthetic excitatory amino acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL11491095A IL114910A (en) 1994-08-12 1995-08-11 Synthetic excitatory amino acids their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (2) US5925782A (en)
EP (1) EP0696577B1 (en)
JP (1) JP2883297B2 (en)
CN (1) CN1066135C (en)
AP (1) AP758A (en)
AT (1) ATE172186T1 (en)
AU (2) AU692276B2 (en)
BG (1) BG62728B1 (en)
CA (1) CA2156024C (en)
CZ (1) CZ291270B6 (en)
DE (1) DE69505318T2 (en)
DK (1) DK0696577T3 (en)
ES (1) ES2122456T3 (en)
FI (1) FI114861B (en)
HK (1) HK1013983A1 (en)
HU (1) HU223845B1 (en)
IL (2) IL114910A (en)
MY (1) MY115977A (en)
NO (1) NO306342B1 (en)
NZ (1) NZ272772A (en)
PL (1) PL182285B1 (en)
RO (1) RO119147B1 (en)
SK (1) SK281288B6 (en)
TW (1) TW438741B (en)
WO (1) WO1996005175A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118727A (en) * 1995-06-29 2003-01-12 Lilly Co Eli (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid
BR9611521A (en) 1995-11-16 1999-06-29 Lilly Co Eli Exciting amino acid receptor antagonists
ZA969485B (en) * 1995-11-16 1998-05-12 Lilly Co Eli Excitatory amino acid receptor antagonists.
US5912248A (en) * 1995-11-16 1999-06-15 Eli Lilly And Company Excitatory amino acid receptor antagonists
AU703409B2 (en) * 1995-11-16 1999-03-25 Eli Lilly And Company Excitatory amino acid derivatives
GB9605429D0 (en) * 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
US5688826A (en) * 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
HUP0001062A3 (en) 1996-09-27 2001-09-28 Guilford Pharmaceuticals Inc B Pharmaceutical compositions of phosphinic acid derivatives having naaladase inhibitor acivity
WO1998032436A1 (en) * 1997-01-29 1998-07-30 Eli Lilly And Company Treatment for premenstrual dysphoric disorder
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
SI0891978T1 (en) * 1997-07-18 2002-06-30 F. Hoffmann-La Roche Ag 5H-Thiazolo (3,2-a) pyrimidine derivatives
EP1000015A1 (en) * 1997-07-18 2000-05-17 Georgetown University Bicyclic metabotropic glutamate receptor ligands
JP3727791B2 (en) * 1998-01-08 2005-12-14 ファイザー・プロダクツ・インク Bicyclic [3.1.0] hexane and related compounds
PT1052246E (en) 1998-01-28 2003-06-30 Taisho Pharmaceutical Co Ltd AMINO ACID DERIVATIVES CONTAINING FLUOR
US5933378A (en) * 1998-02-26 1999-08-03 Micron Technology, Inc. Integrated circuit having forced substrate test mode with improved substrate isolation
EP1396273A1 (en) * 1998-03-17 2004-03-10 Pfizer Products Inc. Bicyclo(2.2.1.)heptanes and related compounds
US6136861A (en) * 1998-03-17 2000-10-24 Pfizer Inc Bicyclo[2.2.1]heptanes and related compounds
GB9815542D0 (en) * 1998-07-17 1998-09-16 Lilly Co Eli Bicyclohexane derivatives
ES2222715T3 (en) 1998-08-31 2005-02-01 Taisho Pharmaceutical Co. Ltd. DERIVATIVES OF 6-FLUOROBICICLO (3.1.0) HEXANO.
CH694053A5 (en) * 1998-09-03 2004-06-30 Hoffmann La Roche Ver method for the production of 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivatives.
JP4192331B2 (en) 1999-04-16 2008-12-10 住友化学株式会社 Process for producing optically active 2-oxobicyclo [3.1.0] hexane-6-carboxylic acid derivative
JP4783967B2 (en) * 1999-07-21 2011-09-28 大正製薬株式会社 Pharmaceuticals containing fluorine-containing amino acid derivatives as active ingredients
GB2355982A (en) * 1999-11-03 2001-05-09 Lilly Co Eli Heterocyclic amino acids
EP1310480A1 (en) * 2001-11-07 2003-05-14 Eli Lilly & Company Prodrugs of excitatory amino acids
US7256217B2 (en) * 2001-01-11 2007-08-14 Eli Lilly And Company Prodrugs of excitatory amino acids
EP1351925A1 (en) 2001-01-11 2003-10-15 Eli Lilly And Company Prodrugs of excitatory amino acids
EP1463713A1 (en) * 2001-11-23 2004-10-06 Eli Lilly And Company Prodrugs of excitatory amino acids
WO2003057661A1 (en) * 2001-12-21 2003-07-17 Eli Lilly And Company Prodrugs of excitatory amino acids
US7456221B2 (en) 2001-12-21 2008-11-25 Eli Lilly And Company Prodrugs of excitatory amino acids
US20040116489A1 (en) * 2002-02-12 2004-06-17 Massey Steven Marc Synthetic excitatory amino acids
JP4964593B2 (en) * 2003-09-25 2012-07-04 セノメド バイオサイエンシーズ,エルエルシー Tetrahydroindolone derivatives for the treatment of neurological conditions
US20050107439A1 (en) * 2003-11-10 2005-05-19 Helton David R. Composition and method for treating emesis
WO2009062134A1 (en) * 2007-11-09 2009-05-14 Cenomed Biosciences, Llc Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
US20090264443A1 (en) * 2008-04-18 2009-10-22 David Helton Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
WO2010111080A2 (en) 2009-03-27 2010-09-30 Eli Lilly And Company Optimized treatment of schizophrenia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3704312A (en) * 1970-10-30 1972-11-28 American Home Prod Bialicyclic amino acids
US3746495A (en) * 1971-06-01 1973-07-17 American Home Prod Anti-ulcer therapy
GB9325368D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
US5661184A (en) * 1994-08-12 1997-08-26 Eli Lilly And Company Psychiatric agents

Also Published As

Publication number Publication date
RO119147B1 (en) 2004-04-30
SK13397A3 (en) 1997-07-09
AP758A (en) 1999-09-10
CN1066135C (en) 2001-05-23
DE69505318T2 (en) 1999-03-25
NZ272772A (en) 1997-10-24
ES2122456T3 (en) 1998-12-16
JP2883297B2 (en) 1999-04-19
CN1123272A (en) 1996-05-29
BG101213A (en) 1998-03-31
IL114910A (en) 2000-06-29
HU223845B1 (en) 2005-02-28
CA2156024C (en) 2004-10-05
MY115977A (en) 2003-10-31
EP0696577B1 (en) 1998-10-14
ATE172186T1 (en) 1998-10-15
FI953837A (en) 1996-02-13
FI114861B (en) 2005-01-14
CA2156024A1 (en) 1996-02-13
HU9502380D0 (en) 1996-05-28
DK0696577T3 (en) 1999-06-23
HK1013983A1 (en) 1999-09-17
AP9700922A0 (en) 1997-01-31
NO953191L (en) 1996-02-13
US5925680A (en) 1999-07-20
SK281288B6 (en) 2001-02-12
DE69505318D1 (en) 1998-11-19
AU2853095A (en) 1996-02-22
EP0696577A1 (en) 1996-02-14
CZ207495A3 (en) 1996-05-15
BG62728B1 (en) 2000-06-30
WO1996005175A1 (en) 1996-02-22
JPH08188561A (en) 1996-07-23
NO953191D0 (en) 1995-08-14
AU3325195A (en) 1996-03-07
PL182285B1 (en) 2001-12-31
CZ291270B6 (en) 2003-01-15
IL114910A0 (en) 1995-12-08
AU692276B2 (en) 1998-06-04
TW438741B (en) 2001-06-07
PL309972A1 (en) 1996-02-19
US5925782A (en) 1999-07-20
HUT75524A (en) 1997-05-28
FI953837A0 (en) 1995-08-14
NO306342B1 (en) 1999-10-25

Similar Documents

Publication Publication Date Title
IL133493A0 (en) Intermediates for the preparation of synthetic excitatory amino acids
HUP9900422A3 (en) Novel protein and methods for the production of the same
HUP0000810A3 (en) Proteins with enhanced levels of essential amino acids
NO992245D0 (en) Process for the preparation of amino carboxylic acids
SI0964856T1 (en) Bicyclic amino acids
ZA9810669B (en) Process for the preparation of 8-methoxy-quinolone-carbyxylic acids
IL132532A (en) Intermediates for the preparation of substituted cephalosporins
IL121730A0 (en) Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
AU3226397A (en) Process for the preparation of chiral keto-heterocycles of basic amino acids
SI1043332T1 (en) Dipeptides comprising cyclopentan-beta-amino acids
IL113142A0 (en) Process for the preparation of 5-hydroxyisophthalic acids
IL122817A0 (en) MP 52 ARG protein
IL120715A0 (en) Process for the preparation of trifluoroethoxy-arenecarboxylic acids
HUP9903751A3 (en) Intermediates for the preparation of 2-imidazoline-5-ones
PL317853A1 (en) Derivatives of amino acids
GB9413316D0 (en) Novel proteins
EP0945433A4 (en) Process for the preparation of acyloxyalkanesulfonic acids
NZ318771A (en) Phenylacetic acids, processes and intermediates for their preparation and agents compositions comprising them
HUP9901345A3 (en) Novel quinoxaline- and quinoxalinylalkane-phosphonic acids
SI0696577T1 (en) Synthetic excitatory amino acids
AU2026897A (en) A process for the preparation of alpha-arylpropionic acids and the intermediates thereof
HUP9600316A2 (en) Process for the preparation of n-(ortho-alkyl-phenyl)-imides
AU3361093A (en) Use of muramyl peptides for enhancing animal production
ZA956773B (en) Synthetic excitatory amino acids.
GB2316073B (en) Alkylation of amino acids

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed